Eli Lilly Writes a Check. AC Immune Surges 15%. Is This Strategy or Spare Change?

Life Science

Intel Joins Musk’s Terafab. Is It Enough to Fix a $7 Billion Problem?

Technology

Is the Sharp Decline of Meta’s Stock in 2026 a Buying Opportunity or a Falling Knife?

Technology

FDA’s Wrath Sends ImmunityBio Stock Down Over 3%

Life Science

Microsoft’s Valuation Just Matched the S&P 500 – Is the 30% Sell-Off a Once-in-a-Decade Opportunity?

Technology

Barrick Mining’s Stock Surges 136% in a Year, Should Investors Hold On?

Mining, Precious Metals

Goldman Sachs Waits for a Turnaround in Private Credit Markets to Seize the Advantage in the Credit Cycle 

Financial Service

NVIDIA’s P/E Ratio Falls Below S&P 500 for First Time in a Decade,  Opportunity or Risk?

Technology

Short Squeeze Drives Bitcoin Above $70,000, Market Sentiment Warms Up in Short Term

Cryptocurrency, Technology

VIX Up 73% – 3 ‘Slow and Steady’ ETFs to Tame Market Turmoil

Consumer Goods, Financial Service

Why the Fed’s “Higher for Longer” Could Be a Nightmare for AI Stocks in 2026

Financial Service, Technology

Nvidia and Meta Both Bet on Nebius – Up 400% in a Year, Is It the Next CoreWeave?

Technology

Tesla’s Future Isn’t Cars — It’s Robotaxis and Humanoids. Will the Bet Pay Off?

Technology

These Two Healthcare Dividend Stocks Offer a Safe Haven As Tech Stocks Keep Falling

Life Science

Amazon Eyeing $9 Billion Globalstar Acquisition – Satellite Stocks Erupt

Technology